Botanix Pharmaceuticals Limited BXPHF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 14.70% | -28.66% | -119.49% | -217.72% | -510.81% |
| Total Depreciation and Amortization | 7.20% | 37.27% | 92.52% | 252.51% | 2,971.91% |
| Total Amortization of Deferred Charges | -46.83% | 55.23% | -- | -- | -- |
| Total Other Non-Cash Items | -53.06% | 47.76% | 1,074.45% | 572.14% | 351.77% |
| Change in Net Operating Assets | 53.70% | -58.97% | -1,619.41% | -1,619.41% | -1,619.41% |
| Cash from Operations | 13.24% | -28.43% | -117.94% | -250.82% | -849.89% |
| Capital Expenditure | 100.11% | 56.76% | -13.88% | -66.81% | -148.51% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 47.16% | 82.00% | 88.83% | 94.50% | 95.69% |
| Cash from Investing | 61.29% | 79.81% | 84.61% | 92.43% | 94.15% |
| Total Debt Issued | -- | 0.00% | -- | -- | -- |
| Total Debt Repaid | -1,469.16% | -1,221.48% | -447.08% | -759.74% | -- |
| Issuance of Common Stock | 11.27% | -25.04% | -45.16% | -53.70% | -59.88% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -63.90% | -48.27% | -35.90% | 9.55% | 42.53% |
| Cash from Financing | -37.75% | -24.20% | -12.70% | -24.83% | -33.66% |
| Foreign Exchange rate Adjustments | 289.92% | -155.25% | -173.79% | -172.00% | -163.83% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -84.78% | -403.65% | -157.60% | -132.34% | -121.84% |